Steering Committee Meeting
April 20-21, 2022
Bethesda, MD
Main Purpose
Celebrate 10 years of the Collaboratory program with discussions on the evolution and current landscape of embedded pragmatic clinical trials (ePCTs); share thoughts on priorities for the future of ePCTs, including how to better serve diverse populations; hear updates on progress and transition plans, as well as challenges and lessons learned, from the UG3 NIH Collaboratory Trials; and learn about the latest bioethics activities in the NIH Collaboratory.
Wednesday, April 20, 2022
Welcome and Opening Remarks
Helene Langevin, MD, PhD; Richard Hodes, MD; Lesley Curtis, PhD
Celebrate the success of the Collaboratory and describe the roadmap for its future
Moderator: Josie Briggs, MD
- Cathy Meyers, MD
- Wendy Weber, ND, PhD, MPH
Then, Now, and the Future…
Moderator: Adrian Hernandez, MD, MHS
The NIH's perspective on how the Collaboratory has propelled embedded pragmatic research throughout the NIH
This panel of contributors from throughout the Collaboratory's history will discuss the program's influence on the evolution of ePCTs over the past decade, including methodologic advances, surprising takeaways, and best practices generated from supporting over 20 large-scale trials within health systems.
Looking at the Landscape of National ePCT Initiatives
Presentations on lessons learned from the Collaboratory and the work of other ongoing pragmatic trial programs
- PCORI: Anne Trontell, MD, MPH
- NIH-DoD-VA Pain Management Collaboratory: Robert Kerns, PhD
- IMPACT Collaboratory: Partha Bhattacharyya, PhD
- HEAL Initiative: Wendy Weber, ND, PhD, MPH
- Mental Health Research Network: Greg Simon, MD, MPH
Navigating the Challenges of Including Diverse Participants
Panel discussion questions:
1. Are ePCTs answering questions that are high priority for health systems that serve diverse patient populations?
2. How can we build capacity and infrastructure across institutions with fewer resources?
3. How do we develop a pipeline of diverse investigators across diverse sites?
Moderator: Rosa Gonzalez-Guarda, PhD, MPH, RN, CPH, FAAN
- Karen Kehl, PhD, RN, FPCN
- Rachel Gold, PhD, MPH
- Julie Fritz, PhD, PT
- Natalia Morone, MD
- Mitch Knisely, PhD, RN-BC, ACNS-BC
- Gloria Coronado, PhD
Update on lessons learned from Year 1, ongoing transition issues, sustainability for the UH3 phase, and any challenges. Discuss the UG3’s current data sharing plans.
Christine Goertz, DC, PhD; Adam Goode, PT, DPT, PhD; Jon Lurie, MD, MS; Hrishikesh Chakraborty, DrPH
Closing Remarks/Adjourn
Helene Langevin, MD, PhD; Richard Hodes, MD; Lesley Curtis, PhD
10th Anniversary Celebration
Posters
- One Decade of NIH Pragmatic Trials Collaboratory (Milestone Timeline)
- Pragmatic Trials in Action: NIH Collaboratory Trials
- Core Accomplishments
- Sharing Our Knowledge
- Publications Highlights
- Pragmatic Trial Training
- Pragmatic Research During COVID-19
- Partners in Progress
Thursday, April 21, 2022
Welcome and Opening Remarks
Helene Langevin, MD, PhD; David Shurtleff, PhD; Richard Hodes, MD; Lesley Curtis, PhD
Perspectives From Our Federal Partners
U.S. Food and Drug Administration
Discuss how to generate evidence at a very large scale, especially for chronic health conditions like pain management
- Rob Califf, MD
Centers for Medicare & Medicaid Services
- Lee Fleisher, MD
HHS OS-Patient-Centered Outcomes Research Trust Fund
Share projects that may be of interest to Collaboratory investigators such as data linkages and social determinants of health data
- Nancy DeLew, MA, MPA
Unanticipated Challenges
The NIH Collaboratory Trials on this panel encountered unanticipated challenges that caused them to change the randomization scheme of their trial. With the help of the Biostatistics and Study Design Core, we will explore the challenges, solutions, and lessons learned as part of this process.
Moderators: Patrick Heagerty, PhD; David Murray, PhD
Barriers and Challenges: Patient, Clinician, and Healthcare System Engagement
Of all the activities in ePCTs, patient, clinician, and healthcare system engagement is continuously ranked one of the most challenging by NIH Collaboratory Trials. Enrollment and engagement of participants is hard, as is engaging with clinicians, providers, and healthcare systems’ leaders throughout the life cycle of a study. We will discuss challenges encountered and solutions for engaging stakeholders to ensure a successful trial.
Moderator: Eric Larson, MD, MPH
- FM-TIPS: Kathleen Sluka, PT, PhD
- OPTIMUM: Natalia Morone, MD
- Nudge: Sheana Bull, MD
- BeatPain Utah: Julie Fritz, PhD, PT
Barriers and Challenges: Data Collection and Merging Data Sets
Collecting and aggregating data from diverse data sets, including the electronic health record, patient-report outcomes, and claims data, involves many expected and unexpected challenges. We will learn about the data-related barriers encountered by NIH Collaboratory Trials, their solutions, and their suggestions for future trials.
Moderator: Keith Marsolo, PhD
- EMBED: Ted Melnick, MD, MHS
- NOHARM: Andrea Cheville, MD, MSCE
- ICD-Pieces: Holt Oliver, MD, PhD
- GGC4H: Margaret Kuklinski, PhD
Successfully implementing and delivering an intervention across multiple organizations is dependent on many factors, including the complexity of the intervention, the stability of the control, and barriers to and promoters of uptake. We will learn from the NIH Collaboratory Trials’ experiences with implementation.
Moderator: Steven George, PhD
- PRIM-ER: Corita Grudzen, MD, MSHS, FACEP
- GRACE: Mitch Knisely, PhD, RN-BC, ACNS-BC
- ACP PEACE: James Tulsky, MD
- BackInAction: Karen Sherman, PhD, MPH
Bioethics Supplement Activities
An update on the activities of the Bioethics Supplement
Stephanie Morain, PhD
Closing Remarks
Helene Langevin, MD, PhD; Richard Hodes, MD; Lesley Curtis, PhD
NIH-Hosted Workshop: Critical Questions for Pragmatic Clinical Trialists: Insights From the NIH Pragmatic Trials Collaboratory’s First Decade
This 2-day workshop held during June 2022 is an opportunity to glean the most salient lessons learned from an experienced group of pragmatic trial investigators who openly shared the challenges they have encountered, solutions they have developed, and thoughts for the future.